| Date | Title | Description |
| 23.05.2024 | Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024 | SUZHOU, China, May 23, 2024 /PRNewswire/ -- On May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma (R/R mRCC) in an o... |
| 14.09.2023 | Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases | SUZHOU, China and HONG KONG, Sept. 14, 2023 /PRNewswire/ -- Cure Genetics and Frametact Limited, a biotech company specializing in researching and developing treatments for neurological diseases, jointly announce the signing of a collaborat... |
| 05.01.2022 | China Digest: Cure Genetics nets $60m; Atom Bioscience raises over $47m | Chinese biotech startup Cure Genetics has secured $60 million in a Series B round. Separately, the country’s pharmaceutical firm Atom Bioscience has raised over 300 million yuan ($47.2 million) to fund the clinical development of its drug c... |
| 08.08.2018 | Term Sheet — Wednesday, August 8 | FUNDING SECURED
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Minutes later, chaos ensued, shares rose, and frantic reporters scrambled to figure out what was going on. Let’s deconstruct.
W... |
| 07.08.2018 | Term Sheet — Tuesday, August 7 | MEDIA MONEY
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
NewTV is a venture under Katzenberg’s umbrella company WndrCo, which has invested in startups such as Mixcloud, Axios, Node, Flowsp... |
| 06.08.2018 | CureGenetics Raises $17M in Series A Financing | CureGenetics Co., Ltd, a Suzhou, China-based biotechnology company dedicated to the development of life-saving medicines and molecular diagnostics using gene editing technologies, closed $17m in Series A financing.
The round was led by Qimi... |
